N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses
- PMID: 1505148
- DOI: 10.1038/clpt.1992.121
N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses
Abstract
The effects of N-acetylcysteine, a sulfhydryl group donor, on nitroglycerin-induced headache and dilation of temporal and radial arteries were investigated in 11 healthy volunteers. Nitroglycerin, 0.06 microgram/kg/min, was infused for 20 minutes immediately after and 120 minutes after pretreatment with N-acetylcysteine (100 mg/kg) or placebo. Arterial diameters were measured with high frequency ultrasound, and pain was scored by use of a previously evaluated 10-point scale. Plasma levels of free (n = 2) and total (n = 11) N-acetylcysteine were determined. N-Acetylcysteine potentiated the headache response (median headache score, 3 versus 1), and the headache retained its vascular characteristics. Temporal artery dilation was also potentiated by N-acetylcysteine, 139% +/- 3% versus 127% +/- 3% of baseline, whereas the radial artery was unaffected. The potentiation was most pronounced after the first nitroglycerin infusion (12% versus 4.5% compared with placebo). A prolonged dilation of the temporal artery was observed only after the first nitroglycerin infusion, when high levels of N-acetylcysteine were present.
Similar articles
-
Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin.Eur J Clin Pharmacol. 1993;44(1):47-50. doi: 10.1007/BF00315279. Eur J Clin Pharmacol. 1993. PMID: 8436154 Clinical Trial.
-
Altered peripheral vasodilator profile of nitroglycerin during long-term infusion of N-acetylcysteine.J Am Coll Cardiol. 1994 Jan;23(1):163-9. doi: 10.1016/0735-1097(94)90515-0. J Am Coll Cardiol. 1994. PMID: 8277075 Clinical Trial.
-
Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate.Eur J Clin Pharmacol. 1992;42(1):31-5. doi: 10.1007/BF00314916. Eur J Clin Pharmacol. 1992. PMID: 1541314
-
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs.Cephalalgia. 1996 Oct;16(6):412-8. doi: 10.1046/j.1468-2982.1996.1606412.x. Cephalalgia. 1996. PMID: 8902249 Clinical Trial.
-
Clevidipine: a review of its use in the management of acute hypertension.Am J Cardiovasc Drugs. 2009;9(2):117-34. doi: 10.2165/00129784-200909020-00006. Am J Cardiovasc Drugs. 2009. PMID: 19331440 Review.
Cited by
-
Inhibition of nitric oxide biosynthesis and carotid arteriovenous anastomotic shunting in the pig.Br J Pharmacol. 1994 Mar;111(3):961-7. doi: 10.1111/j.1476-5381.1994.tb14833.x. Br J Pharmacol. 1994. PMID: 8019774 Free PMC article.
-
Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin.Eur J Clin Pharmacol. 1993;44(1):47-50. doi: 10.1007/BF00315279. Eur J Clin Pharmacol. 1993. PMID: 8436154 Clinical Trial.
-
The effect of nitric oxide donors on haemodynamics and blood flow distribution in the porcine carotid circulation.Br J Pharmacol. 1995 Mar;114(6):1303-9. doi: 10.1111/j.1476-5381.1995.tb13347.x. Br J Pharmacol. 1995. PMID: 7620722 Free PMC article.
-
Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine.Eur J Clin Pharmacol. 1996;49(5):335-9. doi: 10.1007/BF00203773. Eur J Clin Pharmacol. 1996. PMID: 8866624 Clinical Trial.
-
The autonomic nervous system and the regulation of arterial tone in migraine.Clin Auton Res. 1995 Oct;5(5):243-50. doi: 10.1007/BF01818887. Clin Auton Res. 1995. PMID: 8563455 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical